Gene expression profiling for identification, monitoring and treatment of multiple sclerosis

Details for Australian Patent Application No. 2007272824 (hide)

Owner Source Precision Medicine, Inc. d/b/a Source MDX

Inventors Bankaitis-Davis, Danute; Tyron, Victor; Bevilacqua, Michael; Wassmann, Karl; Siconolfi, Lisa; Trollinger, David B.

Agent Cullen & Co

Pub. Number AU-A-2007272824

PCT Pub. Number WO2008/008487

Priority 60/831,005 13.07.06 US

Filing date 13 July 2007

Wipo publication date 17 January 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/008487 Priority application(s): WO2008/008487

23 June 2011 Assignment before Grant

  Source Precision Medicine, Inc. d/b/a Source MDX The application has been assigned to Life Technologies Corporation 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272830-Alkyne-substituted pyridone compounds and methods of use

2007272804-Attenuation of reperfusion injury